The Securities Commission has granted Mindset Pharma Inc. an order to cease being a reporting issuer in all Canadian jurisdictions where it previously held this status. This decision is based on the following key points:
1. Mindset Pharma Inc. is not an OTC reporting issuer as per Multilateral Instrument 51-105.
2. The company’s securities are held by fewer than 15 security holders in each Canadian jurisdiction and less than 51 holders worldwide.
3. There is no active trading of the company’s securities on any marketplace or facility where trading data is publicly reported.
4. Mindset Pharma Inc. has requested to cease being a reporting issuer in all Canadian jurisdictions where it is recognized as such.
5. The company is not in violation of any securities legislation in any jurisdiction.
The Ontario Securities Commission, acting as the principal regulator, has determined that the company meets the necessary criteria outlined in the applicable securities legislation, specifically section 1(10)(a)(ii) of the Securities Act (Ontario) and the relevant policies, including National Policy 11-206 and Multilateral Instrument 11-102. Consequently, the order to cease being a reporting issuer has been approved.